Tue, Jul 22, 2014, 4:27 AM EDT - U.S. Markets open in 5 hrs 3 mins

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

  • aruba270155 aruba270155 Jan 22, 2013 11:40 AM Flag

    FWIW: MKM Partners comments of today

    Amarin: NCE status still uncertain; launch trends are what matter now- MKM Partners (8.28 -0.19)

    MKM Partners notes that the FDA once again failed to rule on regulatory exclusivity for Amarin's Vascepa. This is the sixth delay to the NCE decision, and they continue to assume that Amarin will be unable to successfully petition the FDA to grant Vascepa NCE status. With the next Orange Book update not expected until around February 15 and the Vascepa launch expected in the next two weeks, they think both investors and potential acquirers will focus on early Vascepa prescription and sales trends, making a fast launch extremely important. They also think it is unlikely that Amarin will be acquired before the ANCHOR indication expected approval in late 2013.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.52+0.01(+0.66%)Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.